495 related articles for article (PubMed ID: 29016805)
1. Dissecting human gliomas by single-cell RNA sequencing.
Tirosh I; Suvà ML
Neuro Oncol; 2018 Jan; 20(1):37-43. PubMed ID: 29016805
[TBL] [Abstract][Full Text] [Related]
2. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq.
Venteicher AS; Tirosh I; Hebert C; Yizhak K; Neftel C; Filbin MG; Hovestadt V; Escalante LE; Shaw ML; Rodman C; Gillespie SM; Dionne D; Luo CC; Ravichandran H; Mylvaganam R; Mount C; Onozato ML; Nahed BV; Wakimoto H; Curry WT; Iafrate AJ; Rivera MN; Frosch MP; Golub TR; Brastianos PK; Getz G; Patel AP; Monje M; Cahill DP; Rozenblatt-Rosen O; Louis DN; Bernstein BE; Regev A; Suvà ML
Science; 2017 Mar; 355(6332):. PubMed ID: 28360267
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of a nine-gene signature in glioma patients based on tumor-associated macrophages expression profiling.
Shan X; Zhang C; Wang Z; Wang K; Wang J; Qiu X; Jiang T; Yang P
Clin Immunol; 2020 Jul; 216():108430. PubMed ID: 32325251
[TBL] [Abstract][Full Text] [Related]
4. Single-Cell RNA-Sequencing in Glioma.
Johnson E; Dickerson KL; Connolly ID; Hayden Gephart M
Curr Oncol Rep; 2018 Apr; 20(5):42. PubMed ID: 29637300
[TBL] [Abstract][Full Text] [Related]
5. Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas.
Bourkoula E; Mangoni D; Ius T; Pucer A; Isola M; Musiello D; Marzinotto S; Toffoletto B; Sorrentino M; Palma A; Caponnetto F; Gregoraci G; Vindigni M; Pizzolitto S; Falconieri G; De Maglio G; Pecile V; Ruaro ME; Gri G; Parisse P; Casalis L; Scoles G; Skrap M; Beltrami CA; Beltrami AP; Cesselli D
Stem Cells; 2014 May; 32(5):1239-53. PubMed ID: 24375787
[TBL] [Abstract][Full Text] [Related]
6. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
Zhao B; Bian EB; Li J; Li J
J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
[TBL] [Abstract][Full Text] [Related]
7. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic Crosstalk between Gliomas and Telencephalic Neural Stem and Progenitor Cells for Defining Heterogeneity and Targeted Signaling Pathways.
Deleanu R; Ceafalan LC; Dricu A
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948008
[TBL] [Abstract][Full Text] [Related]
9. The Glioma Stem Cell Model in the Era of Single-Cell Genomics.
Suvà ML; Tirosh I
Cancer Cell; 2020 May; 37(5):630-636. PubMed ID: 32396858
[TBL] [Abstract][Full Text] [Related]
10. Rodent Models to Analyze the Glioma Microenvironment.
Hetze S; Sure U; Schedlowski M; Hadamitzky M; Barthel L
ASN Neuro; 2021; 13():17590914211005074. PubMed ID: 33874781
[TBL] [Abstract][Full Text] [Related]
11. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A
Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845
[TBL] [Abstract][Full Text] [Related]
12. DHHC protein family targets different subsets of glioma stem cells in specific niches.
Chen X; Hu L; Yang H; Ma H; Ye K; Zhao C; Zhao Z; Dai H; Wang H; Fang Z
J Exp Clin Cancer Res; 2019 Jan; 38(1):25. PubMed ID: 30658672
[TBL] [Abstract][Full Text] [Related]
13. Tumor Purity as an Underlying Key Factor in Glioma.
Zhang C; Cheng W; Ren X; Wang Z; Liu X; Li G; Han S; Jiang T; Wu A
Clin Cancer Res; 2017 Oct; 23(20):6279-6291. PubMed ID: 28754819
[No Abstract] [Full Text] [Related]
14. Comparative expression analysis reveals lineage relationships between human and murine gliomas and a dominance of glial signatures during tumor propagation in vitro.
Henriquez NV; Forshew T; Tatevossian R; Ellis M; Richard-Loendt A; Rogers H; Jacques TS; Reitboeck PG; Pearce K; Sheer D; Grundy RG; Brandner S
Cancer Res; 2013 Sep; 73(18):5834-44. PubMed ID: 23887970
[TBL] [Abstract][Full Text] [Related]
15. Review: low-grade gliomas as neurodevelopmental disorders: insights from mouse models of neurofibromatosis-1.
Thangarajh M; Gutmann DH
Neuropathol Appl Neurobiol; 2012 Jun; 38(3):241-53. PubMed ID: 22035280
[TBL] [Abstract][Full Text] [Related]
16. [Aberrant expression of sox2 gene in malignant gliomas].
Volnitskiĭ AV; Semenova EV; Shtam TA; Kovalev RA; Filatov MV
Tsitologiia; 2014; 56(7):504-10. PubMed ID: 25696994
[TBL] [Abstract][Full Text] [Related]
17. Genetic, cellular, and connectomic characterization of the brain regions commonly plagued by glioma.
Mandal AS; Romero-Garcia R; Hart MG; Suckling J
Brain; 2020 Dec; 143(11):3294-3307. PubMed ID: 33278823
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma.
Qi Y; Chen D; Lu Q; Yao Y; Ji C
Dis Markers; 2019; 2019():3917040. PubMed ID: 31885736
[TBL] [Abstract][Full Text] [Related]
19. Immune Cytolytic Activity Is Associated With Genetic and Clinical Properties of Glioma.
Wang ZL; Wang Z; Li GZ; Wang QW; Bao ZS; Zhang CB; Jiang T
Front Immunol; 2019; 10():1756. PubMed ID: 31428092
[No Abstract] [Full Text] [Related]
20. The unique immune ecosystems in pediatric brain tumors: integrating single-cell and bulk RNA-sequencing.
Cao L; Xie W; Ma W; Zhao H; Wang J; Liang Z; Tian S; Wang B; Ma J
Front Immunol; 2023; 14():1238684. PubMed ID: 38094301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]